Lova L. Sun, MD, MSCE
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

203 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
very good experience
September 2025
she's the best.
September 2025
excellent information provided, with detailed layman's language answers.
August 2025
dr sun is very responsive

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Sun is a Penn Medicine physician.

Qualifications and experience

My research

Gobillot TA, Weinstein G, Cao A, Lee JJ, Brody RM, Basu D, O'Malley BW Jr, Farwell DG, Cannady S, Lin A, Lukens J, Gentile M, Newman JG, Chalian AA, Sun L, Lakshmipathy D, Cohen RB, Rasskeh CH, Rajasekaran K. Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery , Laryngoscope: 2025


Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X, Brown EJ, You J, Mirabello L, Mishra SK, Shimunov D, Brody RM, Pearson AT, Gimotty PA, Diab A, Jalaly JB, Basu D. Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer , J Natl Cancer Inst, 117: 2025,1366-1376


Sun L, Marmarelis ME, Aggarwal C. Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer , J Clin Oncol, 43(13): 2025


Cohen RB, Jimeno A, Hreno J, Sun L, Wallén-Öhman M, Millrud CR, Sanfridson A, Garcia-Ribas I. Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors , Invest New Drugs: 2025


Barsouk A, Elghawy O, Watts A, Reed-Guy L, Tompkins W, Chandrasekhara K, Grady CB, Iams W, Sun F, Liu G, Patel D, Nieva JJ, Marrone KA, Velcheti V, Liu SV, Patil T, Weiss J, Schwartzman W, Villaruz LC, Hermann A, Aisner DL, Hwang WT, Camidge DR, Sun L, Singh AP, Cohen RB, Aggarwal C, Langer CJ, Marmarelis ME. Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis , Lung Cancer, 203(108551): 2025


Elghawy O, Barsouk A, Reed-Guy L, Stalker M, Sussman J, Robinson K, Kosteva J, Singh A, Cohen RB, Langer C, Ciunci C, D'Avella C, Sun L, Marmarelis ME, Aggarwal C. Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy , Clin Lung Cancer, 26(2): 2025,158-163.e2


Melina E Marmarelis 1 2, Dylan G Scholes 1 3, Tara L McWilliams 4 5, Wei-Ting Hwang 2 4 5, John Kosteva 1, Michael R Costello 1, Lova Sun 1 2, Aditi P Singh 1 2, Kelsey S Lau-Min 6, Abigail Doucette 2 3, Peter E Gabriel 2 3 7, Anthony O Martella 3, Megan A Roy 1 2, Jeffrey C Thompson 2 8, Roger B Cohen 1 2, David W Dougherty 1 2, Lawrence N Shulman 1 2 3, Corey J Langer 1 2, Justin E Bekelman 2 3 7, Erica L Carpenter 1 2, Charu Aggarwal 1 2 3 Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial , JCO Oncol Pract, 20(12): 2024


Jacob B Reibel 1, Lova L Sun 1, Ravi B Parikh 1 2, Nadim Mahmud 3 4, Lainie P Martin 1, Rebecca A Hubbard 5, Ronac Mamtani 1 Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer , J Natl Cancer Inst, 117: 2024,1276-1278


Connor B Grady 1, Wei-Ting Hwang 1, Joshua E Reuss 2, Wade Iams 3, Amanda Cass 3, Geoffrey Liu 4, Devalben Patel 4, Stephen V Liu 2, Gabriela Liliana Bravo Montenegro 2, Tejas Patil 5, Jorge J Nieva 6, Amanda Herrmann 6, Kristen A Marrone 7, Vincent K Lam 7, William Schwartzman 8, Jonathan Dowell 8, Liza C Villaruz 9, Kelsey Leigh Miller 10, Jared Weiss 10, Fangdi Sun 11, Vamsidhar Velcheti 12, D Ross Camidge 5, Charu Aggarwal 13, Lova Sun 13, Melina E Marmarelis 13 Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer , Pharmacoepidemiol Drug Saf, 33(12): 2024


Glenn J Hanna 1, Jamie Jabalee 2, John N Lukens 3, Lova Sun 3, Eleni M Rettig 4, Rocco Ferrandino 2nd 5, Marshall R Posner 5, Krzysztof J Misiukiewicz 5, David M Routman 6, Kathryn M Van Abel 6, Catherine Del Vecchio Fitz 2, Scott A Roof 5 Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer , Oral Oncol, 158: 2024